Last Updated: August 3, 2026

CALCIUM CHLORIDE 10% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Chloride 10%, and what generic alternatives are available?

Calcium Chloride 10% is a drug marketed by Am Regent, Amneal, Extrovis, Intl Medication Sys, Medefil Inc, Somerset, Square Pharms Plc, and Hospira. and is included in eight NDAs.

The generic ingredient in CALCIUM CHLORIDE 10% is calcium chloride. There are two hundred and eighty-two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the calcium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CALCIUM CHLORIDE 10%?
  • What are the global sales for CALCIUM CHLORIDE 10%?
  • What is Average Wholesale Price for CALCIUM CHLORIDE 10%?
Summary for CALCIUM CHLORIDE 10%
US Patents:0
Applicants:8
NDAs:8
Finished Product Suppliers / Packagers: 14
DailyMed Link:CALCIUM CHLORIDE 10% at DailyMed
Pharmacology for CALCIUM CHLORIDE 10%

US Patents and Regulatory Information for CALCIUM CHLORIDE 10%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 209088-001 Jul 27, 2017 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Square Pharms Plc CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 217463-001 Sep 29, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Intl Medication Sys CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 203477-001 May 9, 2018 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER calcium chloride INJECTABLE;INJECTION 021117-001 Jan 28, 2000 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amneal CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 217524-001 Jul 8, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Extrovis CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 219342-001 Nov 27, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Somerset CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 218133-001 Dec 17, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.